RMB advised Mediclinic on its R8.4-bn acquisition of a 29.9% stake in LSE listed Spire Healthcare Group plc and R10-bn rights issue.
RMB advised Mediclinic on its R32-bn reverse take-over of Abu Dhabi-based Al Noor Hospitals Group plc and primary listing on the London Stock Exchange.
RMB acted as advisor and sponsor to Sanlam in its acquisition of a majority shareholding in AfroCentric. This transaction will add strong healthcare capabilities to Sanlam’s already broad offering.
RMB, leveraging parent company FirstRand’s SPIRE fund, facilitated a project to upgrade a general ward to a Medical Acute Care Unit at Chris Hani Baragwanath Academic Hospital.
Africa’s population growth is expected to rise, resulting in an increased need for high quality, accessible healthcare and a requirement to service the future tourism and hospitality demand across the continent.
